LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹671 Cr | ₹623 Cr | ₹581 Cr | ₹510 Cr | ₹472 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹671 Cr |
| Mar2025 | ₹623 Cr |
| Mar2024 | ₹581 Cr |
| Mar2023 | ₹510 Cr |
| Mar2022 | ₹472 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹671 Cr | 7.67 | |
| Mar2025 | ₹623 Cr | 7.35 | |
| Mar2024 | ₹581 Cr | 13.76 | |
| Mar2023 | ₹510 Cr | 8.09 | |
| Mar2022 | ₹472 Cr | - | |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,036.8 Cr | 2.1% | -5.8% | -0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.1% |
-5.8% |
-0.9% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses